Search for: "MG" Results 421 - 440 of 2,139
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2019, 9:47 am by Sander van Rijnswou
For appraisal of drug safety, the first four patients received escalating doses of ICI 182780, starting with 100 mg in the first month and increasing to 250 mg i.m. from the second month onwards, following confirmation of lack of local or systemic drug toxicity at the 100 mg dose". [read post]
10 Mar 2019, 4:54 am by Anders Valentin
Anders ValentinOn 1 February 2019, the Danish Maritime and Commercial Court granted an injunction against Mylan AB’s sale of the product Tadalafil »Mylan« containing 5 mg tadalafil in Denmark. [read post]
3 Mar 2019, 12:38 pm
The license agreement granted MGI the right to distribute, promote, market, and sell the 0.25 mg and 0.75 mg doses of palonosetron in the United States. [read post]
21 Feb 2019, 2:00 pm by Tom Lamb
Ac­cord­ing to the com­pany, rheuma­toid arthri­tis pa­tients tak­ing a 10 mg dose of Xel­janz (to­fac­i­tinib) in an on­go­ing safety study are being moved to a 5 mg dose after the in­de­pen­dent mon­i­tor­ing board de­ter­mined that there was an im­bal­ance in the rate of death be­tween the 10 mg drug arm (twice daily) and both their 5 mg arm and a group tak­ing a… [read post]
17 Feb 2019, 7:15 am by Robert Schaffer & Joseph Robinson
Patent 7,267,820 (the 820 Patent) discovered that about 20% of patients with the neurological disorder myasthenia gravis (MG) generate autoantibodies to a membrane protein called MuSK. [read post]
14 Feb 2019, 10:00 pm
As stated in Part 1, at issue in Athena was an admitted novel and non-obvious diagnostic test that worked for the 20% of the population suffering from myasthenia gravis (MG) to be diagnosed. [read post]
14 Feb 2019, 9:00 am
The latest volume of the Yearbook of International Humanitarian Law (Vol. 20, 2017) is out. [read post]
14 Feb 2019, 4:01 am by Administrator
Periodically on Thursdays, we present a significant excerpt, usually from a recently published book or journal article. [read post]
11 Feb 2019, 10:00 pm
The method could diagnose MG in the 20% of individuals that every current diagnostic for which there was no current diagnostic. [read post]
11 Feb 2019, 12:15 pm by Overhauser Law Offices, LLC
(collectively “Teva”) sought approval to market a generic 0.25 mg palonosetron product. [read post]
11 Feb 2019, 12:00 am by Thorsten Bausch
Howell was used as CPAD by the Opponents, since it described a Phase II clinical trial, in which a formulation containing 50 mg/ml fulvestrant in a castor oil-based vehicle was intramuscularly administered to patients having a tamoxifen-resistant breast cancer. [read post]
6 Feb 2019, 10:48 am by Dennis Crouch
So, the key discovery here was the relationship between MuSK autoantibody production and MG. [read post]
4 Feb 2019, 2:01 am
In particular the claim specifies that the separator tube is either (1) a glass tube containing thixotropic gel and 0.10 M sodium citrate, or (2) a polyethylene terephthalate separator tube containing a highly thixotropic gel formed by a polymer mixture and anhydrous sodium citrate at 3.5 mg/mL. [read post]
1 Feb 2019, 6:19 am by Robert Kraft
” The report adds that “the toothpicks are often infused or coated with nicotine and can have as much as 3 mg of nicotine, compared to the about 1.5 mg of nicotine most smokers inhale from a cigarette. [read post]
31 Jan 2019, 8:32 am
In early 2000, Helsinn submitted protocols for Phase III clinical trials to the Food and Drug Administration (FDA), proposing to study a 0.25 mg and a 0.75 mg dose of palonosetron. [read post]
31 Jan 2019, 6:49 am by Paula Lombardi
The Regulations also propose removing the partial prohibition on the export of waste containing PCBs in concentrations equal to, or greater than, 50 mg/kg. [read post]
31 Jan 2019, 1:00 am by DONALD SCARINCI
(Teva) filed an abbreviated new drug application (ANDA) seeking FDA approval to market a generic version of Helsinn’s 0.25 mg palonosetron product. [read post]
15 Jan 2019, 4:00 pm by Cannabis Law Group
., 10 mg may be a safe dose for someone who is healthy and 25, but what about someone who is 65?). [read post]
11 Jan 2019, 9:05 pm by Joe Whitworth
Results have shown levels of Paralytic Shellfish Poisoning (PSP) toxins above the limit of 0.8 mg/kg set by the agency. [read post]
9 Jan 2019, 1:05 pm by Daily Record Staff
., received FDA approval to develop Bretylium Tosylate Injection USP, 500 mg/10 mL (50 mg/mL) Single-Dose Vials. [read post]